4//SEC Filing
Townsend Richard Nolan 4
Accession 0001415889-25-022473
CIK 0001907108other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 5:00 PM ET
Size
4.9 KB
Accession
0001415889-25-022473
Insider Transaction Report
Form 4
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-08-18$4.67/sh−2,735$12,767→ 220,058 total
Footnotes (2)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]Includes 131,092 RSUs.
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
Related Parties
1- filerCIK 0001995218
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 5:00 PM ET
- Size
- 4.9 KB